Clinical Study Into the Cosmetic Results of Leukosan Adhesive
Launched by DR. STEPHANIE KRAUSE · Jun 30, 2014
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
The medical devices compared were EU (European Union) approved market-ready products with relevant designation according to the legal requirements for medical devices and according to Council guideline 93/42/EWG dated 14th July.
Leukosan Adhesive is a sterile, ultra high viscose adhesive for external skin closure. Due to the skin's moisture, this skin adhesive polymerizes within seconds into a flexible film firmly holding the edges of the wound together and protecting the wound itself.
Premilene DSMP 24, 3/8 needle, thread 3/0 denier was used a a comparison. This suture material was the s...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female between 18 and 60
- • Undergone laparoscopic operation with 2 mirror image trocar incisions
- • Willing to attend examination at clinic at 7-12 days and 10-14 weeks
- • Signed agreement by participant
- Exclusion Criteria:
- • Length of laparoscopic operation more than 2 hours
- • Hospitalisation due to complications
- • Circumstances leading to difference in trocar incisions
- • Existing scar less than 3 cm from the operation point
- • Diabetic condition melitis HbA1c\>9mg/d
- • Known allergy to tissue adhesive
- • Participation in another study within 30 days
About Dr. Stephanie Krause
Dr. Stephanie Krause is a dedicated clinical trial sponsor with extensive expertise in medical research and a strong commitment to advancing healthcare innovation. With a focus on enhancing patient outcomes, she leads clinical trials that explore cutting-edge treatments and therapies across various therapeutic areas. Dr. Krause is renowned for her meticulous approach to trial design, regulatory compliance, and data integrity, ensuring that all studies adhere to the highest ethical standards. Her collaborative spirit fosters strong partnerships with research institutions and healthcare professionals, driving progress in clinical research and contributing significantly to the field of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamburg, , Germany
Patients applied
Trial Officials
Olaf Buchweitz, Priv.Doz.
Principal Investigator
Tagesklinik Altonaer Strasse
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials